Twlbio
1 known investors
TWL Bio develops an immunotherapy platform that trains the immune system to target pathological proteins driving chronic, lifelong conditions, positioned as an alternative to costly monoclonal antibody infusions. Its work spans neurology and immunology, including research linking HERV-K to ALS.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Twlbio do?
- TWL Bio develops an immunotherapy platform that trains the immune system to target pathological proteins driving chronic, lifelong conditions, positioned as an alternative to costly monoclonal antibody infusions. Its work spans neurology and immunology, including research linking HERV-K to ALS.
- Who are Twlbio's investors?
- Twlbio's investors include Formation Venture Engineering.